Prevalence of Musculoskeletal Complaints in Nursing Home Residents
Launched by MAASTRICHT UNIVERSITY MEDICAL CENTER · Jan 23, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying joint pain and other musculoskeletal issues among nursing home residents, both those with and without dementia. The main goal is to find out how many residents have tender or swollen joints and how they feel about their joint pain. For residents who can communicate, the study will also look at their mobility and check if their medical records accurately describe their joint problems. Those with dementia will be asked simpler questions about their pain, while others will answer a few more detailed questions about their health and pain levels.
To participate, residents must be at least 65 years old. One group includes residents who are mentally competent and do not have dementia, while the other group includes residents diagnosed with dementia, whose legal representatives will provide consent. Participants will undergo a standard physical exam, and the study will ensure that no sensitive or intrusive questions are asked. The findings from this study could help improve the understanding and care of joint issues in nursing home residents.
Gender
ALL
Eligibility criteria
- Inclusion criteria, group 1:
- • Mentally competent nursing home resident ≥ 65 years;
- • No diagnosis of dementia (major neurocognitive disorder according to DSM-5 criteria);
- • The nursing home resident provides informed consent to participate in the study.
- Inclusion criteria, group 2:
- • Nursing home resident with dementia (major neurocognitive disorder according to DSM-5 criteria) ≥ 65 years;
- • The legal representative of the nursing home resident provides informed consent to participate in the study.
- Exclusion criteria, group 1:
- • Diagnosis dementia;
- • Life expectancy \< 2 weeks (definition terminal nursing home resident). Exclusion criteria, group 2
- • Life expectancy \< 2 weeks (definition terminal nursing home resident).
- • If, on the basis of an already known pattern of behaviour, it is expected that the potential participant will resist the proposed research (anticipated behaviour).
About Maastricht University Medical Center
Maastricht University Medical Center (MUMC+) is a leading academic medical center in the Netherlands, renowned for its commitment to advancing healthcare through innovative research and education. As a prominent sponsor of clinical trials, MUMC+ integrates cutting-edge scientific inquiry with clinical practice, focusing on a wide range of medical disciplines. The center emphasizes collaboration among multidisciplinary teams, fostering an environment that promotes excellence in patient care and the translation of research findings into clinical applications. MUMC+ is dedicated to improving health outcomes and enhancing quality of life through rigorous clinical investigations and the development of novel therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brunssum, Limburg, Netherlands
Patients applied
Trial Officials
Marloes van Onna, MD; PhD
Principal Investigator
Maastricht University Medical Centre
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported